Advertisement

BioMetals

pp 1–14 | Cite as

DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II) complex

  • Zhanfen ChenEmail author
  • Yixuan Wu
  • Zhenzhu Zhu
  • Yumin Zhang
Article
  • 53 Downloads

Abstract

A novel phenolate-bridged binuclear copper(II) complex, [Cu 2 II (L–3H)Cl] (1, where L = 2,6-bis[((2-hydroxybenzyl)(2-pyridylmethyl)amino)methyl]-4-methylphenol), have been synthesized and characterized. The antiproliferative activity of the complex has been tested in vitro against the human cervical cancer cell line HeLa, human non-small-cell lung cancer cell line A-549, the human breast cancer cell line MCF-7, and the human hepatic cell line LO2. The results show the complex has the low micromolar range (9.4–11.2 µM) of IC50 values towards the three cancer cell lines, which is markedly comparable to those of cisplatin. However 1 exhibited 10.6-fold less toxicity than cisplatin toward normal cells LO2, suggesting that complex 1 had high selectivity between tumor cells and normal cells. The interactions with DNA were investigated by UV–Vis absorption, fluorescence, circular dichroism, and gel electrophoresis. The results show that the copper(II) complex could strongly bind to DNA mainly by the groove binding mode and efficiently cleave the pBR322 plasmid DNA into its nicked and linear forms in the presence of excessive ascorbic acid. In addition, the evaluation of the protein binding ability shows that complex 1 could bind to human serum albumin (HSA) with a moderate binding affinity and quench the intrinsic fluorescence of HSA.

Keywords

Binuclear copper(II) complex Antiproliferative activity DNA cleavage DNA binding Human serum albumin 

Notes

Acknowledgements

We acknowledge the financial support from the Natural Science Foundation of Hubei Province (No. 2018CFB658) and the Opening Project of Key Laboratory of Optoelectronic Chemical Materials and Devices, Ministry of Education, Jianghan University (No. JDGD-201810).

Supplementary material

10534_2019_172_MOESM1_ESM.doc (413 kb)
Supplementary material 1 (DOC 414 kb)

References

  1. Abou-Zied OK, Al-Shihi OIK (2008) Characterization of subdomain IIA binding site of human serum albumin in its native, unfolded, and refolded states using small molecular probes. J Am Chem Soc 130:10793–10801CrossRefGoogle Scholar
  2. Alagesan M, Bhuvanesh NSP, Dharmaraj N (2014) Binuclear copper complexes: synthesis, X-ray structure and interaction study with nucleotide/protein by in vitro biochemical and electrochemical analysis. Eur J Med Chem 78:281–293CrossRefGoogle Scholar
  3. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601Google Scholar
  4. Baguley BC, LeBret M (1984) Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect. Biochemistry 23:937–943CrossRefGoogle Scholar
  5. Bi SY, Song DQ, Tian Y, Zhou X, Liu ZY, Zhang HQ (2005) Molecular spectroscopic study on the interaction of tetracyclines with serum albumins. Spectrochim Acta Part A 61:629–636CrossRefGoogle Scholar
  6. Biswas N, Khanra S, Sarkar A, Bhattacharjee S, Manda DP, Chaudhuri A, Chakraborty S, Choudhury CR (2017) One new azido bridged dinuclear copper(II) thiosemicarbazide complex: synthesis, DNA/protein binding, molecular docking study and cytotoxicity activity. New J Chem 41:12996–13011CrossRefGoogle Scholar
  7. Bloomfield VA, Crothers DM, Tinoco I (1974) Physical chemistry of nucleic acids. Harper and Row, New York, p 432Google Scholar
  8. Chen ZF, Zhang J, Zhang SP (2015) Oxidative DNA cleavage promoted by two phenolate-bridged binuclear copper(II) complexes. New J Chem 39:1814–1821CrossRefGoogle Scholar
  9. da Silveira VC, Luz JS, Oliveira CC, Graziani I, Ciriolo MR, da Costa Ferreira AM (2008) Double-strand DNA cleavage induced by oxindole-schiff base copper(II) complexes with potential antitumor activity. J Inorg Biochem 102:1090–1103CrossRefGoogle Scholar
  10. Denoyer D, Masaldan S, La Fontaine S, Cater MA (2015) Targeting copper in cancer therapy: ‘copper that cancer’. Metallomics 7:1459–1476CrossRefGoogle Scholar
  11. Eftink MR, Ghiron CA (1976) Fluorescence quenching of indole and model micelle systems. J Phys Chem 80:486–493CrossRefGoogle Scholar
  12. Frey ST, Sun HHJ, Murthy NN, Karlin KD (1996) A new trinuclear copper complex and its reactions with plasmid DNA. Inorg Chem Acta 242:329–338CrossRefGoogle Scholar
  13. Ganeshpandian M, Ramakrishnan S, Palaniandavar M, Suresh E, Riyasdeen A, Akbarsha MA (2014) Mixed ligand copper(II) complexes of 2,9-dimethyl-1,10-phenanthroline: tridentate 3N primary ligands determine DNA binding and cleavage and cytotoxicity. J Inorg Biochem 140:202–212CrossRefGoogle Scholar
  14. Gao WH, Li NN, Chen YW, Xu YP, Lin YJ, Yin YG, Hu ZD (2010) Study of interaction between syringing and human serum albumin by multi-spectroscopic method and atomic force microscopy. J Mol Struct 983:133–140CrossRefGoogle Scholar
  15. Geary WJ (1971) The use of conductivity measurements in organic solvents for the characterization of coordination compounds. Coord Chem Rev 7:81–122CrossRefGoogle Scholar
  16. Groessl M, Terenghi M, Casini A, Elviri L, Lobinski R, Dyson PJ (2010) Reavtivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS. J Anal At Spectrom 25:305–313CrossRefGoogle Scholar
  17. Haworth IS, Elcock AH, Freeman J, Rodger A, Richards WG (1991) Sequence selective binding to the DNA major groove: tris(1,10-phenanthronline) metal complexes binding to poly(dG-dC) and poly(dA-dT). J Biomol Struct Dyn 9:23–43CrossRefGoogle Scholar
  18. He XM, Carter DC (1992) Atomic structure and chemistry of human serum albumin. Nature 358:209–215CrossRefGoogle Scholar
  19. Hu W, Luo Q, Wu K, Li X, Wang F, Chen Y, Ma X, Wang J, Liu J, Xiong S, Sadler PJ (2011) The anticancer drug cisplatin can cross-link the interdomain zinc site to human albumin. Chem Commun 47:6006–6008CrossRefGoogle Scholar
  20. Iakovidis I, Delimaris I, Piperakis SM (2011) Copper and its complexes in medicine: a biochemical approach. Mol Biol Int 2011:594529CrossRefGoogle Scholar
  21. Ibrahim N, Ibrahim H, Kim S, Nallet JP, Nepveu F (2010) Interactions between antimalarial indolone-N-oxide derivatives and human serum albumin. Biomacromolecules 11:3341–3351CrossRefGoogle Scholar
  22. Jamieson ER, Lippard SJ (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99:2467–2498CrossRefGoogle Scholar
  23. Jin Y, Cowan JA (2005) DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA. J Am Chem Soc 127:8408–8415CrossRefGoogle Scholar
  24. Johnson JR (1994) CD of nucleic acids. In: Nakanishi K, Berova N, Woody RW (eds) Circular dichroism: principles and applications. VCH, New York, pp 523–540Google Scholar
  25. Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584CrossRefGoogle Scholar
  26. Kellett A, O’Connor M, McCann M, Howe O, Casey A, McCarron P, Kavanagh K, McNamara M, Kennedy S, May DD, Skell PS, O’Shea D, Devereux M (2011) Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development. Med Chem Commun 2:579–584CrossRefGoogle Scholar
  27. Kim BE, Nevitt T, Thiele DJ (2008) Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 4:176–185CrossRefGoogle Scholar
  28. Krebs B, Schepers K, Bremer B, Henkel G, Althaus E, Müller-Warmuth W, Griesar K, Haase W (1994) Model compounds for the oxidized uteroferrin-phosphate complex with novel dinucleating ligands containing phenolate and pyridine donors. Inorg Chem 33:1907–1914CrossRefGoogle Scholar
  29. Kurtz DM (1990) Oxo- and hydroxo-bridged diiron complexes: a chemical perspectivie on a biological unit. Chem Rev 90:585–606CrossRefGoogle Scholar
  30. Lahiri D, Bhowmick T, Pathak B, Shameema O, Patra AK, Ramakumar S, Chakravarty AR (2009) Anaerobic photocleavage of DNA in red light by dicopper(II) complexes of 3,3′-dithiodipropionic acid. Inorg Chem 48:339–349CrossRefGoogle Scholar
  31. Laitinen OH, Hytonen VP, Nordlund HR, Kulomaa MS (2006) Genetically engineered avidins and streptavidins. Cell Mol Life Sci 63:2992–3017CrossRefGoogle Scholar
  32. Lakowicz JR, Weber G (1973) Quenching of fluorescence by oxygen. A probe for structural fluctuations in macromolecules. Biochemistry 12:4161–4170CrossRefGoogle Scholar
  33. Li XW, Li YT, Wu ZY, Yan CW (2012) Syntheses and structures of bicopper(II) complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxamide: cytotoxic activities, and reactivities towards DNA and protein. Inorg Chim Acta 390:190–198CrossRefGoogle Scholar
  34. Li DD, Zhang N, Dai LL, Yang ZB, Tao ZW (2016) Synthesis, DNA binding, nuclease activity and cytotoxic studies of a wheel-shaped octanuclear copper(II) complex based on 1,2,4-triazole. Appl Organometal Chem 30:346–353CrossRefGoogle Scholar
  35. Lian WJ, Wang XT, Xie CZ, Tian H, Song XQ, Pan HT, Qiao X, Xu JY (2016) Mixed-ligand copper(II) schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity. Dalton Trans 45:9073–9087CrossRefGoogle Scholar
  36. Lin XD, Liu YH, Xie CZ, Bao WG, Shen J, Xu JY (2017) Three Pt(II) complexes based on thiosemicarbazone: synthesis, HSA interaction, cytotoxicity, apoptosis and cell cycle arrest. RSC Adv 7:26478–26486CrossRefGoogle Scholar
  37. Maity B, Roy M, Saha S, Chakravarty AR (2009) Photoinduced DNA and protein cleavage activity of ferrocene-conjugated ternary copper(II) complexes. Organometallics 28:1495–1505CrossRefGoogle Scholar
  38. Malati MA (1999) Experimental inorganic/physical chemistry. Woodhead Publishing, CambridgeGoogle Scholar
  39. Marmur J (1961) A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3:208–218CrossRefGoogle Scholar
  40. Marzano C, Pellei M, Tisato F, Santini C (2009) Copper complexes as anticancer agents. Anti-Cancer Agents Med Chem 9:185–211CrossRefGoogle Scholar
  41. Mazuryk O, Niemiec E, Stochel G, Gillaizeau I, Brindell M (2013) Benzothiophen-pyrazine scaffold as a potential membrane targeting drug carrier. J Lumin 140:51–56CrossRefGoogle Scholar
  42. Meyer-Almes FJ, Porschke D (1993) Mechanism of intercalation into the DNA double helix by ethidium. Biochemstry 32:4246–4253CrossRefGoogle Scholar
  43. Mirica LM, Ottenwaelder X, Stack TDP (2004) Structure and spectroscopy of copper-dioxygen complexes. Chem Rev 104:1013–1045CrossRefGoogle Scholar
  44. Pasternack RF, Caccam M, Keogh B, Stephenson TA, Williams AP, Gibbs EJ (1991) Studies on the binding of pepstatin and its derivatives to rhizopus pepsin by quantum mechanics, molecular mechanics, and free energy perturbation methods. J Am Chem Soc 113:6835–6840CrossRefGoogle Scholar
  45. Qi JX, Liang SC, Gou Y, Zhang ZL, Zhou ZP, Yang F, Liang H (2015) Synthesis of four binuclear copper(II) complexes: structure, anticancer properties and anticancer mechanism. Eur J Med Chem 96:360–368CrossRefGoogle Scholar
  46. Raja DS, Bhuvanesh NSP, Natarajan K (2011) Biological evaluation of a novel water soluble sulphur bridged binuclear copper(II) thiosemicarbazone complex. Eur J Med Chem 46:4584–4594CrossRefGoogle Scholar
  47. Raja DS, Bhuvanesh NSP, Natarajan K (2012) DNA binding, protein interaction, radical scavenging and cytotoxic activity of 2-oxo-1,2-dihydroquinoquinoline-3-carbaldehyde(2′-hydroxybenzoyl)hydrazone and its Cu(II) complexes: a structure activity relation study. Inorg Chim Acta 385:81–93CrossRefGoogle Scholar
  48. Reichmann ME, Rice SA, Thomas CA, Doty P (1954) A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76:3047–3053CrossRefGoogle Scholar
  49. Ruiz-Azuara L, Bravo-Gómez ME (2010) Copper compounds in cancer chemotherapy. Curr Med Chem 17:3606–3615CrossRefGoogle Scholar
  50. Samari F, Hemmateenejad B, Shamsipur M, Rashidi M, Samouei H (2012) Affinity of two novel five-coordinated anticancer Pt(II) complexes to human and bovine serum albumins: a spectroscopic approach. Inorg Chem 51:3454–3464CrossRefGoogle Scholar
  51. Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C (2014) Advances in copper complexes as anticancer agents. Chem Rev 114:815–862CrossRefGoogle Scholar
  52. Sheng X, Lu XM, Chen YT, Lu GY, Zhang JJ, Shao Y, Liu F, Xu Q (2007) Synthesis, DNA-binding, cleavage, and cytotoxic activity of new 1,7-dioxa-4,10-diazacyclododecane artificial receptors containing bisguanidinoethyl or diaminoethyl double side arms. Chem Eur J 13:9703–9712CrossRefGoogle Scholar
  53. Shi SY, Zhang YP, Chen XQ, Peng MJ (2011) Investigation of flavonoids bearing different substituents on ring C and their Cu2+ complex binding with bovine serum albumin: structure-affinity relationship aspects. J Agric Food Chem 59:10761–10769CrossRefGoogle Scholar
  54. Tabassum S, Al-Asbahy WM, Afzal M, Arjmand F, Khan RH (2012) Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study. Mol BioSyst 8:2424–2433CrossRefGoogle Scholar
  55. Tisato F, Marzano C, Porchia M, Pellei M, Santini C (2010) Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 30:708–749Google Scholar
  56. Tolia C, Papadopoulos AN, Raptopoulou CP, Psycharis V, Garino C, Salassa L, Psomas G (2013) Copper(II) interacting with the non-steroidal anti-inflammatory drug flufenamic acid: structure, antioxidant activity and binding to DNA and albumins. J Inorg Biochem 123:53–65CrossRefGoogle Scholar
  57. Tysoe SA, Morgan RJ, Baker AD, Strekas TC (1993) Spectroscopic investigation of differential binding modes of Δ- and Λ-Ru(bpy)2(ppz)2+ with calf thymus DNA. J Phys Chem 97:1707–1711CrossRefGoogle Scholar
  58. Usman M, Arjmand F, Khan RA, Alsalme A, Ahmad M, Tabassumm S (2017) Biological evaluation of dinuclear copper complex/dichloroacetic acid cocrystal against human breast cancer: design, synthesis, characterization, DFT studies and cytotoxicity assays. RSC Adv. 7:47920–47932CrossRefGoogle Scholar
  59. Wolfe A, JrGH Shimer, Meehan T (1987) Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denautured DNA. Biochemistry 26:6392–6396CrossRefGoogle Scholar
  60. Xie ZJ, Yu Z, Chen YC, Lu GY, Guo ZJ, He WJ (2012) DNA cleavage behavior of a new p-xylyl spaced bisCu(BPA)Cl2 complex: the steric effect of a bulky p-xylyl-derived spacer. New J Chem 36:644–649CrossRefGoogle Scholar
  61. Xu XW, Li XJ, Zhan SH, Li YT, Wu ZY, Yan CW (2013) Synthesis and structure of a new tetracopper(II) complex bridged both oxamido and phenolato groups: cytotoxic activity, and reactivity towards DNA and BSA. J Mol Struct 1039:28–36CrossRefGoogle Scholar
  62. Yuan T, Weljie AM, Vogel HJ (1998) Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding. Biochemistry 37:3187–3195CrossRefGoogle Scholar
  63. Zhao YM, Zhu JH, He WJ, Yang Z, Zhu YG, Li YZ, Zhang JF, Guo ZJ (2006) Oxidative DNA cleavage promoted by multinuclear copper complexes: activity dependence on the complex structure. Chem Eur J 12:6621–6629CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Flexible Display Materials & Technology, Co-Innovation Center of Hubei, Key Laboratory of Optoelectronic Chemical Materials and Devices of Ministry of Education, School of Chemistry and Environmental EngineeringJianghan UniversityWuhanPeople’s Republic of China
  2. 2.State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical EngineeringNanjing UniversityNanjingPeople’s Republic of China

Personalised recommendations